Oruka Therapeutics, Inc. ORKA
102.86 USD +6.84 (+7.12%)
At closeNov 9, 2026, 4:01 AM EST
104.41 +1.55 +1.51%
Pre-market · Nov 9, 4:01 AM ET
96.05 Day range 103.75
25.23 52-week range 115.52
- YTD
- +239.36%
- 1 year
- +270.67%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -122.05M | -88.12M | -7.30M | -10.60M | -19.34M | |
| -105.43M | -83.72M | -5.34M | -9.93M | -19.32M | |
| -1.85 | -3.87 | -4.44 | -8.30 | -16.70 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 46.94M | 61.58M | 37.43M | 42.45M | 53.36M | |
| 488.62M | 396.02M | 37.86M | 43.09M | 54.92M | |
| 16.69M | 13.80M | 841.00K | 1.41M | 3.88M | |
| 1.93M | 968.00K | 204.00K | 280.00K | 383.00K | |
| 471.93M | 382.22M | 37.02M | 41.67M | 51.04M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -88.21M | -57.84M | -5.01M | -10.91M | -18.76M | |
| -96.75M | -330.13M | 0 | -2.00K | -43.00K | |
| 170.31M | 449.54M | 0 | 0 | 23.09M | |
| -209.00K | -189.00K | 0 | -2.00K | -43.00K | |
| -14.64M | 61.58M | -5.01M | -10.91M | 4.29M |